Skip to content
Vet-reviewed pet data. Shared only with consent.
Designed to give you structured, vet-reviewed records, limited to what each owner has separately agreed to share, for the purpose you stated and for as long as they allow. Pharma, research and brands are designed to receive only de-identified, aggregated signals.
- Owner consent per partner and per data type, revocable at any time
- A distinct key per partner, every request audit-logged
- Designed so clinical and pet records stay in mainland China
A call is about 30 minutes on Tencent Meeting or WeChat video, or a visit in Shanghai: how the consent-bound data API is designed and where the owner consent screens stand today, then your questions.
Source: share of pets insured — Paidu Pet Industry Big Data Platform, 2026 China Pet Industry White Paper (Consumption Report), January 2026 (to be verified).
Source: urban cats and dogs, yearly spend per dog and per cat, urban cat and dog consumer market — Paidu Pet Industry Big Data Platform, 2026 China Pet Industry White Paper (Consumption Report), January 2026.
Consent first. Then data.
Designed so nothing moves without the owner's separate consent, which the owner can withdraw at any time.
You ask
Name the data types, the purpose and how long you need them.
The owner decides
Each owner allows or declines, one data type at a time; access for an insurer is a separate consent of its own.
Every read is logged
Scoped tokens and a distinct key per partner. Owners can withdraw at any time.
One API.
Only what owners allow.
Tokenised scope per request, designed to follow PIPL, audit-logged, with a distinct key per partner. The basic version is in development; the full enterprise version is on the roadmap.
- Structured records, reviewed by the vet
- Per-pet data only for a partner with the owner's separate consent; research uses receive de-identified, aggregated data only
- Connections to clinics' existing practice-management systems Coming next
Help shape the API
while we build it.
Early partners help decide which data types come first and what the consent screen says. No data moves until owners have consented. An early partnership takes an NDA and a letter of intent, with no fee.
Talk to usWhat you get
- A say in the first data types and the consent screen
- Early access to the basic API once it is ready for testing
- A named contact on the founding team
What we ask
- A stated purpose for the data
- A data-protection contact on your side
- Feedback on the consent flow
Who it's for
- Insurers, pharma and research teams, and pet brands active in China
- Teams comfortable working with a product in development
Bring to the first call
- The intended use, and the data types you need
- Your data-protection contact
- Insurers: your licence (insurer or insurance intermediary)
One record.
Three kinds of partner.
Every card shows where it stands today. The card badge is the partnership as a whole; each line shows the product it depends on.
Licensed insurers and intermediaries
Underwriting on longitudinal care history shared with the owner's separate consent, with enrolment at the vet counter.
- Underwriting Engine Coming next
- Embedded Enrolment at the vet counter Coming next
- Claims validation and direct pay On the roadmap
Designed so policies are quoted, sold and paid only by licensed insurers or licensed insurance intermediaries; Petnest AI provides the technology and, with the owner's separate, revocable consent, the care history. Petnest AI never sells policies.
e.g. an underwriting quote on vaccination history — Case 23 in the library
Pharma & research
Consented cohorts and safety signals. Pharma and research teams are designed to receive only de-identified, aggregated data.
- Population Health Maps Coming next
- Pharmacovigilance NLP On the roadmap
- RWE Study Platform On the roadmap
The RWE Study Platform is designed around a veterinary-drug filing with the Ministry of Agriculture and Rural Affairs; US FDA GFI #266 (2021) serves only as a design benchmark.
e.g. a monthly pharmacovigilance report on a chronic NSAID — Case 27 in the library
Brands
Vet-validated recommendations, from the pet's health, not the ad auction. Brands are designed to receive only de-identified, aggregated data, never a single pet's file.
- Smart Recommender Coming next
- Co-marketing with opt-in cohorts On the roadmap
- Marketplace On the roadmap
e.g. launch districts chosen on health data — Case 43 in the library
Your questions, answered.
Want to go further? Talk to the founding team.
Talk to us
How does consent work for a partner?
You state the data types, the purpose and the duration; each owner separately allows or declines, one data type at a time, and can withdraw at any time. Once consent is withdrawn, the API returns nothing; every read is logged.
What can partners access?
By design, only what an owner has explicitly agreed to share, for the purpose and period you stated: structured, vet-reviewed records such as vaccination history and visit summaries.
Per-pet or aggregated data?
Designed so a single pet's care history goes to an insurer only with the owner's separate, revocable consent; pharma, research and brands receive only de-identified, aggregated data.
How much data is there today?
None yet: the record starts with our design-partner clinics.
Is the API available?
Not yet. The basic consent-bound API is in development, and the snippet on this page is an illustration, not a live API. Early partners help decide which data types come first and get access once the API is ready for testing. Talk to us now to help shape it.
What do you never do?
We never sell a pet's file. Designed so an insurer sees a pet's history only with the owner's separate, revocable consent. We do not sell insurance, and no partner receives data outside what the owner agreed to.
Does Petnest AI sell insurance?
No. Insurance is offered by licensed insurers or licensed insurance intermediaries; Petnest AI provides the technology and, with the owner's consent, the care history.
Where is the data stored?
Designed so clinical and pet records stay in mainland China, with every read and write logged, with identity and scope.
Can a company outside mainland China work with you?
We can talk. Designed so clinical and pet records stay in mainland China; any transfer abroad would have to follow PIPL and the cross-border data rules, with the owner's separate consent.
How do partnerships work commercially?
Agreed project by project; we do not publish prices.
What does an early partnership commit us to?
An NDA and a letter of intent, with no fee. See early partners.
Data that
owners trust.
Insurer, pharma or brand? Tell us what you need, and help decide which data types come first.
The consent-bound data API is in development. No data moves until owners have consented.
Talk to the founding team
A first call: what data, with which consent, for which use. We reply personally from thomas@petnestdata.com within one working day, in Chinese or English.